 John Thompson
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 26 | 2025 | 96 | 10.950 |
Why?
| | Parkinson Disease | 28 | 2025 | 410 | 9.100 |
Why?
| | Subthalamic Nucleus | 14 | 2024 | 47 | 6.920 |
Why?
| | Drug Resistant Epilepsy | 4 | 2024 | 77 | 1.880 |
Why?
| | Epilepsy | 2 | 2025 | 315 | 1.330 |
Why?
| | Globus Pallidus | 3 | 2021 | 20 | 1.300 |
Why?
| | Putamen | 2 | 2020 | 19 | 1.270 |
Why?
| | Sleep Stages | 4 | 2024 | 44 | 1.170 |
Why?
| | Beta Rhythm | 2 | 2024 | 14 | 1.120 |
Why?
| | Basal Ganglia | 3 | 2023 | 51 | 1.110 |
Why?
| | Brain | 6 | 2025 | 2604 | 1.080 |
Why?
| | Brain Waves | 2 | 2017 | 30 | 1.000 |
Why?
| | Sodium Glutamate | 2 | 2016 | 9 | 0.980 |
Why?
| | Solitary Nucleus | 2 | 2016 | 17 | 0.970 |
Why?
| | Pars Reticulata | 2 | 2022 | 5 | 0.970 |
Why?
| | Pedunculopontine Tegmental Nucleus | 2 | 2016 | 4 | 0.970 |
Why?
| | Electrocorticography | 1 | 2025 | 13 | 0.960 |
Why?
| | Electrodes, Implanted | 7 | 2025 | 103 | 0.930 |
Why?
| | Anterior Thalamic Nuclei | 1 | 2024 | 3 | 0.930 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2016 | 173 | 0.920 |
Why?
| | Seizures | 2 | 2025 | 395 | 0.920 |
Why?
| | Neurons | 9 | 2024 | 1437 | 0.870 |
Why?
| | Thalamus | 3 | 2021 | 79 | 0.860 |
Why?
| | Diffusion Tensor Imaging | 3 | 2021 | 69 | 0.830 |
Why?
| | Methylphenidate | 1 | 2022 | 38 | 0.780 |
Why?
| | Hallucinogens | 1 | 2023 | 87 | 0.730 |
Why?
| | Decision Making | 3 | 2018 | 837 | 0.700 |
Why?
| | Caudate Nucleus | 1 | 2020 | 18 | 0.700 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 38 | 0.670 |
Why?
| | Health Literacy | 1 | 2022 | 164 | 0.660 |
Why?
| | Microelectrodes | 4 | 2024 | 40 | 0.640 |
Why?
| | Intraoperative Awareness | 1 | 2018 | 2 | 0.610 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 22 | 0.600 |
Why?
| | Taste Perception | 2 | 2016 | 23 | 0.580 |
Why?
| | Polysomnography | 5 | 2024 | 155 | 0.580 |
Why?
| | White Matter | 1 | 2019 | 129 | 0.580 |
Why?
| | Middle Aged | 23 | 2025 | 31024 | 0.580 |
Why?
| | Humans | 48 | 2025 | 129078 | 0.540 |
Why?
| | Glioma | 2 | 2021 | 348 | 0.530 |
Why?
| | Male | 35 | 2025 | 63248 | 0.530 |
Why?
| | Cannabis | 1 | 2023 | 438 | 0.510 |
Why?
| | Essential Tremor | 3 | 2024 | 12 | 0.510 |
Why?
| | Space Perception | 1 | 2016 | 73 | 0.500 |
Why?
| | Dystonia | 3 | 2024 | 23 | 0.490 |
Why?
| | Mental Recall | 1 | 2016 | 185 | 0.470 |
Why?
| | Choice Behavior | 1 | 2016 | 158 | 0.470 |
Why?
| | Lac Operon | 1 | 2014 | 46 | 0.470 |
Why?
| | Aged | 17 | 2025 | 22068 | 0.460 |
Why?
| | beta-Galactosidase | 1 | 2014 | 75 | 0.460 |
Why?
| | Movement Disorders | 1 | 2014 | 53 | 0.450 |
Why?
| | tau Proteins | 1 | 2014 | 78 | 0.440 |
Why?
| | Neuroma, Acoustic | 2 | 2024 | 41 | 0.420 |
Why?
| | Female | 26 | 2025 | 68274 | 0.420 |
Why?
| | Laser Therapy | 3 | 2021 | 127 | 0.410 |
Why?
| | Dystonic Disorders | 2 | 2024 | 23 | 0.410 |
Why?
| | Tremor | 3 | 2023 | 54 | 0.400 |
Why?
| | Models, Neurological | 1 | 2014 | 235 | 0.400 |
Why?
| | Wakefulness | 3 | 2022 | 115 | 0.400 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3357 | 0.390 |
Why?
| | Hypokinesia | 2 | 2022 | 7 | 0.370 |
Why?
| | Xenobiotics | 1 | 2011 | 29 | 0.360 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2010 | 7 | 0.360 |
Why?
| | Finches | 1 | 2010 | 12 | 0.360 |
Why?
| | Vocalization, Animal | 1 | 2010 | 31 | 0.360 |
Why?
| | Oxidants | 1 | 2011 | 109 | 0.350 |
Why?
| | Pilot Projects | 3 | 2025 | 1548 | 0.350 |
Why?
| | Endocannabinoids | 1 | 2010 | 40 | 0.350 |
Why?
| | Sleep | 3 | 2024 | 657 | 0.340 |
Why?
| | Glutamic Acid | 1 | 2010 | 231 | 0.310 |
Why?
| | Neuronal Plasticity | 1 | 2010 | 261 | 0.300 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 45 | 0.300 |
Why?
| | Action Potentials | 3 | 2024 | 464 | 0.290 |
Why?
| | Carcinogens | 1 | 2008 | 111 | 0.290 |
Why?
| | Learning | 1 | 2010 | 384 | 0.270 |
Why?
| | Electroencephalography | 2 | 2025 | 388 | 0.250 |
Why?
| | Trapezoid Body | 2 | 2016 | 9 | 0.250 |
Why?
| | Implantable Neurostimulators | 1 | 2025 | 8 | 0.240 |
Why?
| | Animals | 14 | 2022 | 34708 | 0.240 |
Why?
| | Motor Activity | 3 | 2021 | 668 | 0.240 |
Why?
| | Adult | 11 | 2025 | 35423 | 0.240 |
Why?
| | Superior Colliculi | 2 | 2015 | 37 | 0.240 |
Why?
| | Cavernous Sinus | 1 | 2024 | 15 | 0.240 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 829 | 0.230 |
Why?
| | Antioxidants | 1 | 2008 | 559 | 0.230 |
Why?
| | Pneumocephalus | 1 | 2024 | 3 | 0.220 |
Why?
| | Young Adult | 4 | 2025 | 12310 | 0.220 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5282 | 0.210 |
Why?
| | Treatment Outcome | 9 | 2024 | 10256 | 0.210 |
Why?
| | Mice, Transgenic | 4 | 2016 | 2082 | 0.210 |
Why?
| | Ear, Inner | 1 | 2023 | 44 | 0.210 |
Why?
| | Taste | 2 | 2016 | 214 | 0.210 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2023 | 36 | 0.210 |
Why?
| | Reward | 2 | 2016 | 238 | 0.200 |
Why?
| | Proof of Concept Study | 1 | 2022 | 63 | 0.200 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2022 | 4 | 0.200 |
Why?
| | Cannabidiol | 1 | 2024 | 88 | 0.200 |
Why?
| | Observer Variation | 1 | 2023 | 322 | 0.200 |
Why?
| | Tertiary Care Centers | 1 | 2023 | 147 | 0.190 |
Why?
| | Dronabinol | 1 | 2024 | 166 | 0.190 |
Why?
| | Substantia Nigra | 1 | 2022 | 51 | 0.190 |
Why?
| | Mice | 8 | 2021 | 16583 | 0.190 |
Why?
| | Skull Base | 2 | 2020 | 42 | 0.190 |
Why?
| | Psychosurgery | 1 | 2021 | 6 | 0.190 |
Why?
| | Upper Extremity | 1 | 2022 | 95 | 0.190 |
Why?
| | Zona Incerta | 1 | 2021 | 2 | 0.190 |
Why?
| | Anesthesia, General | 1 | 2021 | 53 | 0.190 |
Why?
| | Craniotomy | 1 | 2021 | 69 | 0.180 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 170 | 0.180 |
Why?
| | Anticonvulsants | 1 | 2023 | 199 | 0.180 |
Why?
| | Conscious Sedation | 1 | 2021 | 84 | 0.180 |
Why?
| | Retrospective Studies | 7 | 2024 | 14562 | 0.170 |
Why?
| | Consensus | 1 | 2023 | 646 | 0.170 |
Why?
| | Atrophy | 1 | 2020 | 168 | 0.170 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 109 | 0.170 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 123 | 0.160 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 784 | 0.160 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 176 | 0.150 |
Why?
| | Neoplasm Grading | 1 | 2019 | 278 | 0.150 |
Why?
| | Psychoacoustics | 1 | 2018 | 10 | 0.150 |
Why?
| | Corpus Striatum | 1 | 2020 | 153 | 0.150 |
Why?
| | Intraoperative Period | 1 | 2018 | 53 | 0.150 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3047 | 0.150 |
Why?
| | Lung | 1 | 2011 | 3925 | 0.150 |
Why?
| | Behavior, Animal | 1 | 2021 | 486 | 0.150 |
Why?
| | Brain Mapping | 1 | 2021 | 564 | 0.140 |
Why?
| | Psychotic Disorders | 1 | 2020 | 152 | 0.140 |
Why?
| | Neuropsychological Tests | 1 | 2022 | 997 | 0.140 |
Why?
| | Algorithms | 1 | 2025 | 1626 | 0.140 |
Why?
| | Orientation | 2 | 2015 | 43 | 0.140 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 26 | 0.140 |
Why?
| | REM Sleep Behavior Disorder | 1 | 2016 | 13 | 0.140 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1230 | 0.140 |
Why?
| | Biomarkers | 2 | 2025 | 3878 | 0.130 |
Why?
| | Acoustic Stimulation | 1 | 2018 | 321 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 731 | 0.130 |
Why?
| | Stereotaxic Techniques | 1 | 2016 | 35 | 0.130 |
Why?
| | Brain Injuries | 1 | 2021 | 468 | 0.130 |
Why?
| | Grape Seed Extract | 2 | 2013 | 44 | 0.130 |
Why?
| | Drinking | 1 | 2016 | 41 | 0.130 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1286 | 0.130 |
Why?
| | Cadaver | 3 | 2024 | 332 | 0.130 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 559 | 0.130 |
Why?
| | Vision Disorders | 1 | 2017 | 133 | 0.130 |
Why?
| | Amygdala | 1 | 2017 | 182 | 0.120 |
Why?
| | Cues | 1 | 2018 | 319 | 0.120 |
Why?
| | Odorants | 1 | 2016 | 147 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 740 | 0.120 |
Why?
| | Anxiety | 1 | 2022 | 947 | 0.120 |
Why?
| | Stimulation, Chemical | 1 | 2014 | 62 | 0.120 |
Why?
| | Dyskinesias | 1 | 2014 | 19 | 0.120 |
Why?
| | Acetylcholine | 1 | 2015 | 185 | 0.110 |
Why?
| | Synapses | 2 | 2016 | 385 | 0.110 |
Why?
| | Psychometrics | 1 | 2018 | 684 | 0.110 |
Why?
| | Staining and Labeling | 1 | 2014 | 142 | 0.110 |
Why?
| | Membrane Potentials | 1 | 2014 | 261 | 0.110 |
Why?
| | Optogenetics | 1 | 2015 | 113 | 0.110 |
Why?
| | Anthocyanins | 1 | 2013 | 33 | 0.110 |
Why?
| | Neural Inhibition | 1 | 2014 | 152 | 0.110 |
Why?
| | Schizophrenia | 1 | 2017 | 433 | 0.110 |
Why?
| | Symptom Assessment | 1 | 2014 | 127 | 0.110 |
Why?
| | Cytokines | 1 | 2021 | 1997 | 0.110 |
Why?
| | Locomotion | 1 | 2013 | 98 | 0.100 |
Why?
| | Equipment Design | 1 | 2014 | 523 | 0.100 |
Why?
| | Stroke | 1 | 2021 | 1111 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 174 | 0.100 |
Why?
| | Smell | 1 | 2013 | 132 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2013 | 143 | 0.100 |
Why?
| | Hippocampus | 1 | 2017 | 791 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2013 | 187 | 0.100 |
Why?
| | Glucuronides | 1 | 2011 | 14 | 0.100 |
Why?
| | Biflavonoids | 1 | 2011 | 9 | 0.100 |
Why?
| | Proanthocyanidins | 1 | 2011 | 10 | 0.100 |
Why?
| | Microsomes, Liver | 1 | 2011 | 64 | 0.100 |
Why?
| | Catechin | 1 | 2011 | 26 | 0.090 |
Why?
| | Nerve Net | 1 | 2014 | 254 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 23 | 0.090 |
Why?
| | Glutathione Transferase | 1 | 2011 | 98 | 0.090 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 189 | 0.090 |
Why?
| | Endoscopy | 2 | 2024 | 268 | 0.090 |
Why?
| | Dendritic Spines | 1 | 2010 | 59 | 0.090 |
Why?
| | Time Factors | 1 | 2020 | 6579 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 687 | 0.080 |
Why?
| | Glutathione | 1 | 2011 | 333 | 0.080 |
Why?
| | Synaptic Transmission | 1 | 2010 | 261 | 0.080 |
Why?
| | Alkylation | 1 | 2008 | 24 | 0.080 |
Why?
| | Adolescent | 2 | 2025 | 20241 | 0.080 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 578 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 165 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 210 | 0.070 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2357 | 0.070 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2008 | 487 | 0.070 |
Why?
| | Neural Pathways | 2 | 2020 | 291 | 0.060 |
Why?
| | Diphosphonates | 1 | 2006 | 58 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2021 | 3999 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1306 | 0.060 |
Why?
| | Sella Turcica | 1 | 2024 | 16 | 0.060 |
Why?
| | Neuroendoscopy | 1 | 2024 | 20 | 0.060 |
Why?
| | Patch-Clamp Techniques | 2 | 2016 | 262 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2485 | 0.060 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1174 | 0.060 |
Why?
| | Facial Nerve | 1 | 2024 | 35 | 0.060 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2024 | 95 | 0.050 |
Why?
| | Edema | 1 | 2023 | 127 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 840 | 0.050 |
Why?
| | Oxidopamine | 1 | 2021 | 13 | 0.050 |
Why?
| | Adrenergic Agents | 1 | 2021 | 6 | 0.050 |
Why?
| | Parkinson Disease, Secondary | 1 | 2021 | 7 | 0.050 |
Why?
| | Evoked Potentials, Motor | 1 | 2021 | 41 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1697 | 0.050 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 246 | 0.050 |
Why?
| | Corpus Callosum | 1 | 2021 | 64 | 0.050 |
Why?
| | Electric Impedance | 1 | 2020 | 102 | 0.040 |
Why?
| | Nose | 1 | 2020 | 64 | 0.040 |
Why?
| | Fingers | 1 | 2020 | 87 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1864 | 0.040 |
Why?
| | Melanoma | 1 | 2006 | 738 | 0.040 |
Why?
| | Movement | 1 | 2020 | 269 | 0.040 |
Why?
| | Meningioma | 1 | 2018 | 77 | 0.030 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 88 | 0.030 |
Why?
| | Dreams | 1 | 2016 | 11 | 0.030 |
Why?
| | Visual Pathways | 1 | 2017 | 50 | 0.030 |
Why?
| | Visual Fields | 1 | 2017 | 87 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 76 | 0.030 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 2016 | 26 | 0.030 |
Why?
| | Gerbillinae | 1 | 2016 | 64 | 0.030 |
Why?
| | Spinal Cord | 1 | 2018 | 360 | 0.030 |
Why?
| | Spatial Behavior | 1 | 2015 | 22 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2015 | 86 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 159 | 0.030 |
Why?
| | Glycine Plasma Membrane Transport Proteins | 1 | 2014 | 7 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 404 | 0.030 |
Why?
| | Cholera Toxin | 1 | 2014 | 29 | 0.030 |
Why?
| | Rhodamines | 1 | 2014 | 17 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2043 | 0.030 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2014 | 31 | 0.030 |
Why?
| | Electroporation | 1 | 2014 | 37 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 239 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 266 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2014 | 166 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 267 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3336 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2014 | 267 | 0.030 |
Why?
| | Functional Laterality | 1 | 2014 | 217 | 0.030 |
Why?
| | Prognosis | 1 | 2021 | 3793 | 0.030 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1138 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 392 | 0.030 |
Why?
| | Postoperative Complications | 1 | 2024 | 2497 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1061 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 817 | 0.020 |
Why?
| | Dimerization | 1 | 2011 | 189 | 0.020 |
Why?
| | Methylation | 1 | 2011 | 228 | 0.020 |
Why?
| | Palliative Care | 1 | 2017 | 712 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1085 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2711 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7070 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2768 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 4927 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 3137 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3114 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 996 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2344 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2006 | 7063 | 0.010 |
Why?
|
|
Thompson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|